1-8 of 8
Mirca Lazzaretti, PHD
Close
Sort by
Journal Articles

Hypoxia-Inducible Factor (HIF)-1a Is A Therapeutic Target in Myeloma-Induced Angiogenesis and Bone Destruction in Vivo .

Marina Bolzoni, Paola Storti, PhD, Gaetano Donofrio, PhD, Irma Airoldi, PhD, Daniela Guasco, Denise Toscani, Marco Peronaci, Eugenia Martella, MD, Mirca Lazzaretti, PhD, Luca Agnelli, PhD, Ken Patrene, Cristina Mancini, MD, Martine Amiot, PhD, Antonino Neri, Simona Colla, Judith Anderson, Franco Aversa, MD, G. David Roodman, MD, PhD, Nicola Giuliani
Journal: Blood
Blood (2012) 120 (21): 2947.
https://doi.org/10.1182/blood.V120.21.2947.2947
Published: 2012
Journal Articles

Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients

Denise Toscani, Benedetta Dalla Palma, MD, Carla Palumbo, Marzia Ferretti, Marina Bolzoni, Daniela Guasco, Cristina Mancini, MD, Eugenia Martella, MD, Mirca Lazzaretti, PhD, Mario Pedrazzoni, MD, PhD, Franco Aversa, MD, Nicola Giuliani
Journal: Blood
Blood (2012) 120 (21): 3978.
https://doi.org/10.1182/blood.V120.21.3978.3978
Published: 2012
Journal Articles

Hypoxia-Inducible Factor (HIF)-1α Is a Therapeutic Target in Myeloma-Induced Angiogenesis

Paola Storti, PhD, Irma Airoldi, PhD, Marina Bolzoni, Mirca Lazzaretti, PhD, Daniela Guasco, Luca Agnelli, PhD, Eugenia Martella, MD, Cristina Mancini, MD, Antonino Neri, MD, Gaetano Donofrio, PhD, Nicola Giuliani, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 3927.
https://doi.org/10.1182/blood.V118.21.3927.3927
Published: 2011
Journal Articles

The Activation of Wnt5a-Mediated Non Canonical Wnt Signaling in Human Bone Marrow Osteoprogenitor Cells Increases Osteoblastogenesis and Counterbalances the Inhibitory Effect of Myeloma Cells on Ror2/FZD5 Expression,

Marina Bolzoni, Paola Storti, PhD, Daniela Guasco, Mirca Lazzaretti, PhD, Eugenia Martella, MD, Cristina Mancini, MD, Luca Agnelli, PhD, Sabrina Bonomini, Antonino Neri, MD, Gaetano Donofrio, PhD, Nicola Giuliani, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 3928.
https://doi.org/10.1182/blood.V118.21.3928.3928
Published: 2011
Journal Articles

In Vitro and In Vivo Evidences of Osteocyte Involvement In Myeloma-Induced Osteolysis

Nicola Giuliani, MD, PhD, Paola Storti, PhD, Manuela Abeltino, Marina Bolzoni, Marzia Ferretti, Mirca Lazzaretti, PhD, Benedetta Dalla Palma, Katia Todoerti, PhD, Eugenia Martella, MD, Luca Agnelli, Antonino Neri, MD, Vittorio Rizzoli, MD, PhD, Carla Palumbo
Journal: Blood
Blood (2010) 116 (21): 131.
https://doi.org/10.1182/blood.V116.21.131.131
Published: 2010
Journal Articles

Macrophage Inflammatory Protein (MIP)-3α/CCL20 and Its Receptor CCR6 Are Overexpressed in the Bone Microenvironment and Involved in Osteoclast Formation in Multiple Myeloma Patients.

Nicola Giuliani, MD, PhD, Gina Lisignoli, PhD, Sara Tagliaferri, Mirca Lazzaretti, PhD, Francesca Morandi, Simona Colla, PhD, Cristina Manferdini, Beatrice Tonnarelli, Vittorio Rizzoli, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 3510.
https://doi.org/10.1182/blood.V110.11.3510.3510
Published: 2007
Journal Articles

The Proteasome Inhibitor Bortezomib Affects Osteoblastogenesis and Bone Formation In Vitro and In Vivo in Multiple Myeloma Patients.

Nicola Giuliani, MD, PhD, Francesca Morandi, Sara Tagliaferri, Mirca Lazzaretti, PHD, Sabrina Bonomini, Monica Crugnola, MD, Daniela Petrò, MD, Cristina Mancini, MD, Eugenia Martella, MD, Vittorio Rizzoli, MD, PHD
Journal: Blood
Blood (2006) 108 (11): 508.
https://doi.org/10.1182/blood.V108.11.508.508
Published: 2006
Journal Articles

Immunohistologic Identification and Quantification of Human Bone Marrow Hematopoietic Stem Cells.

Federico Quaini, MD, Mirca Lazzaretti, PhD, Lorena Carranza, PhD, Francesca Ferraro, MD, Sabrina Bonomini, PhD, Konrad Urbanek, MD, Cristina Mancini, MD, Nicola Giuliani, MD, Piero Anversa, MD, Vittorio Rizzoli, MD
Journal: Blood
Blood (2005) 106 (11): 2301.
https://doi.org/10.1182/blood.V106.11.2301.2301
Published: 2005